How standard is second-line cetuximab in recurrent or metastatic head and neck cancer in 2017?

Petr Szturz, Tanguy Y. Seiwert, Jan B. Vermorken

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)2229-2231
Number of pages3
JournalJournal of Clinical Oncology
Volume35
Issue number20
DOIs
StatePublished - Jul 10 2017
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this